Clinical Trials Update: Jan. 4, 2011
Type 2 Diabetes Adolescent Migraines Lupus
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Type 2 Diabetes
This study will evaluate different doses of approved type 2 diabetes drugs. You may qualify if you are aged 18 to 85, have type 2 diabetes, and have been on a stable regimen of NPH insulin, Levemir (insulin determir), or Lantus (insulin glargine) and at least one oral diabetic drug for three months.
The research site is in Las Vegas, Nev.
This study will evaluate a nasal spray to treat migraines. Participants must be aged 12 to 17 and be willing to treat one migraine with the study drug exclusively.
The research site is in Colorado Springs, Colo.
This study will evaluate an injected study medication in treating systemic lupus erythematosus (SLE). To qualify, you must not have had an active infection in the last 30 days, and not have a serious infection or blood-clotting event within 90/180 days respectively.
The research site is in Sacramento, Calif.
Copyright 2011 ClinicalConnection.com. All rights reserved.